Literature DB >> 27979364

Immunotherapy and patients treated for cancer with microsatellite instability.

Raphaël Colle1, Romain Cohen2, Delphine Cochereau3, Alex Duval4, Olivier Lascols5, Daniel Lopez-Trabada1, Pauline Afchain1, Isabelle Trouilloud1, Yann Parc6, Jérémie H Lefevre6, Jean-François Fléjou7, Magali Svrcek7, Thierry André8.   

Abstract

Microsatellite instability (MSI) is a tumor phenotype linked to somatic or germline (Lynch syndrome) inactivating alterations of DNA mismatch repair genes. A broad spectrum of neoplasms exhibits MSI phenotype, mainly colorectal cancer, endometrial cancer, and gastric cancer. MSI tumors are characterized by dense immune infiltration and high load of tumor neo-antigens. Growing evidence is accumulating on the efficacy of immune checkpoint inhibition for patients treated for MSI solid tumors. We present a comprehensive overview of MSI phenotype, its biological landscape and current diagnostic methods. Then we focus on MSI as a predictive biomarker of response to immune checkpoint inhibition in the context of colorectal cancer and non-colorectal tumors.
Copyright © 2016 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cancer colorectal; Cancer de l’endomètre; Checkpoint immunitaires; Colorectal cancer; Déficience du système de réparation de l’ADN; Endometrial cancer; Immune checkpoint; Lynch syndrome; Mismatch repair deficiency; Nivolumab; Syndrome de Lynch

Mesh:

Year:  2016        PMID: 27979364     DOI: 10.1016/j.bulcan.2016.11.006

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  16 in total

Review 1.  Mismatch repair-based stratification for immune checkpoint blockade therapy.

Authors:  Lihong Zhang; Yang Peng; Guang Peng
Journal:  Am J Cancer Res       Date:  2018-10-01       Impact factor: 6.166

Review 2.  Exploring immunotherapy in colorectal cancer.

Authors:  Junyong Weng; Shanbao Li; Zhonglin Zhu; Qi Liu; Ruoxin Zhang; Yufei Yang; Xinxiang Li
Journal:  J Hematol Oncol       Date:  2022-07-16       Impact factor: 23.168

3.  Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer.

Authors:  Zhenghang Wang; Qi Zhang; Changsong Qi; Yuezong Bai; Feilong Zhao; Hui Chen; Zhongwu Li; Xicheng Wang; Mifen Chen; Jifang Gong; Zhi Peng; Xiaotian Zhang; Jinping Cai; Shiqing Chen; Xiaochen Zhao; Lin Shen; Jian Li
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

Review 4.  Molecular Biomarkers of Primary and Acquired Resistance to T-Cell-Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future Directions.

Authors:  Young Kwang Chae; Michael S Oh; Francis J Giles
Journal:  Oncologist       Date:  2017-12-14

5.  Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective.

Authors:  Casey Quinn; Louis P Garrison; Anja K Pownell; Michael B Atkins; Gérard de Pouvourville; Kevin Harrington; Paolo Antonio Ascierto; Phil McEwan; Samuel Wagner; John Borrill; Elise Wu
Journal:  J Immunother Cancer       Date:  2020-07       Impact factor: 13.751

6.  Differences in gene mutations according to gender among patients with colorectal cancer.

Authors:  Yi-Jian Tsai; Sheng-Chieh Huang; Hung-Hsin Lin; Chun-Chi Lin; Yuan-Tzu Lan; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Wei-Shone Chen; Tzu-Chen Lin; Jen-Kou Lin; Shih-Ching Chang
Journal:  World J Surg Oncol       Date:  2018-07-05       Impact factor: 2.754

7.  Proteome-transcriptome alignment of molecular portraits achieved by self-contained gene set analysis: Consensus colon cancer subtypes case study.

Authors:  Galina Glazko; Boris Zybailov; Frank Emmert-Streib; Ancha Baranova; Yasir Rahmatallah
Journal:  PLoS One       Date:  2019-08-22       Impact factor: 3.240

Review 8.  Immunotherapy with immune checkpoint inhibitors in colorectal cancer: what is the future beyond deficient mismatch-repair tumours?

Authors:  Nicolas Huyghe; Paméla Baldin; Marc Van den Eynde
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-11-25

Review 9.  Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer.

Authors:  Camille Evrard; Gaëlle Tachon; Violaine Randrian; Lucie Karayan-Tapon; David Tougeron
Journal:  Cancers (Basel)       Date:  2019-10-15       Impact factor: 6.639

Review 10.  Colon Cancer: A Clinician's Perspective in 2019.

Authors:  Monjur Ahmed
Journal:  Gastroenterology Res       Date:  2020-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.